MORPHINE SULFATE — all Canadian products
153 DINs
69 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is MORPHINE SULFATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02559722 | KADIAN | BGP PHARMA ULC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Marketed | |
| 02184443 | KADIAN | BGP PHARMA ULC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 50 MG | Marketed | |
| 02184451 | KADIAN | BGP PHARMA ULC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Marketed | |
| 02242163 | KADIAN | BGP PHARMA ULC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 10 MG | Marketed | |
| 02184435 | KADIAN | BGP PHARMA ULC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 20 MG | Marketed | |
| 02320398 | M-EDIAT | ETHYPHARM INC | Capsule (Immediate-Release) | Oral | MORPHINE SULFATE 5 MG | Marketed | |
| 02320444 | M-EDIAT | ETHYPHARM INC | Capsule (Immediate-Release) | Oral | MORPHINE SULFATE 30 MG | Marketed | |
| 02320436 | M-EDIAT | ETHYPHARM INC | Capsule (Immediate-Release) | Oral | MORPHINE SULFATE 20 MG | Marketed | |
| 02320428 | M-EDIAT | ETHYPHARM INC | Capsule (Immediate-Release) | Oral | MORPHINE SULFATE 10 MG | Marketed | |
| 02177749 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Marketed | |
| 02019949 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Marketed | |
| 02019930 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 10 MG | Marketed | |
| 02177757 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Marketed | |
| 02019957 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Marketed | |
| 02019965 | M-ESLON | ETHYPHARM INC | Capsule (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Marketed | |
| 00617288 | MORPHINE HP 50 | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 50 MG | Marketed | |
| 02021048 | MORPHINE LP EPIDURAL | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Epidural; Subcutaneous | MORPHINE SULFATE 1 MG | Marketed | |
| 02021056 | MORPHINE LP EPIDURAL | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Epidural; Intravenous | MORPHINE SULFATE 0.5 MG | Marketed | |
| 00392588 | MORPHINE SULFATE INJ 10MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | Intramuscular; Subcutaneous; Intravenous | MORPHINE SULFATE 10 MG | Marketed | |
| 00392561 | MORPHINE SULFATE INJ 15MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 15 MG | Marketed | |
| 02500736 | MORPHINE SULFATE INJECTION | JAMP PHARMA CORPORATION | Solution | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 15 MG | Marketed | |
| 02561220 | MORPHINE SULFATE INJECTION | JUNO PHARMA CANADA INC. | Solution | Intravenous; Intramuscular; Subcutaneous | MORPHINE SULFATE 15 MG | Approved | |
| 02500728 | MORPHINE SULFATE INJECTION | JAMP PHARMA CORPORATION | Solution | Subcutaneous; Intravenous; Intramuscular | MORPHINE SULFATE 10 MG | Marketed | |
| 02561212 | MORPHINE SULFATE INJECTION | JUNO PHARMA CANADA INC. | Solution | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 10 MG | Approved | |
| 02500701 | MORPHINE SULFATE INJECTION | JAMP PHARMA CORPORATION | Solution | Intravenous; Intramuscular; Subcutaneous | MORPHINE SULFATE 2 MG | Marketed | |
| 02474999 | MORPHINE SULFATE INJECTION BP | STERIMAX INC | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 15 MG | Approved | |
| 02474980 | MORPHINE SULFATE INJECTION BP | STERIMAX INC | Solution | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 10 MG | Marketed | |
| 02498278 | MORPHINE SULFATE INJECTION EPIDURAL | STERIMAX INC | Solution | Epidural | MORPHINE SULFATE 0.5 MG | Marketed | |
| 02498286 | MORPHINE SULFATE INJECTION EPIDURAL | STERIMAX INC | Solution | Epidural | MORPHINE SULFATE 1 MG | Marketed | |
| 02382997 | MORPHINE SULFATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intravenous; Intramuscular | MORPHINE SULFATE 10 MG | Marketed | |
| 02491885 | MORPHINE SULFATE INJECTION USP | STERINOVA INC. | Solution | Intravenous | MORPHINE SULFATE 50 MG | Approved | |
| 02491931 | MORPHINE SULFATE INJECTION USP | STERINOVA INC. | Solution | Intravenous | MORPHINE SULFATE 100 MG | Marketed | |
| 02242484 | MORPHINE SULFATE INJECTION USP | SANDOZ CANADA INCORPORATED | Liquid | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 2 MG | Marketed | |
| 02488620 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous; Intravenous; Intramuscular | MORPHINE SULFATE 2 MG | Approved | |
| 02488647 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 10 MG | Approved | |
| 02488639 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 4 MG | Approved | |
| 02482746 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Intravenous; Subcutaneous; Intramuscular | MORPHINE SULFATE 10 MG | Marketed | |
| 02482681 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Intravenous; Subcutaneous; Intramuscular | MORPHINE SULFATE 2 MG | Marketed | |
| 02015439 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Marketed | |
| 02014297 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Marketed | |
| 02014300 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Marketed | |
| 02014319 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Marketed | |
| 02014327 | MS CONTIN | PURDUE PHARMA | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Marketed | |
| 02014203 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 5 MG | Marketed | |
| 02014211 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 10 MG | Marketed | |
| 02014238 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 20 MG | Marketed | |
| 02014254 | MS.IR | PURDUE PHARMA | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 30 MG | Marketed | |
| 02549824 | PMS-MORPHINE SULFATE | PHARMASCIENCE INC | Tablet | Oral | MORPHINE SULFATE 50 MG | Approved | |
| 02549794 | PMS-MORPHINE SULFATE | PHARMASCIENCE INC | Tablet | Oral | MORPHINE SULFATE 5 MG | Marketed | |
| 02549808 | PMS-MORPHINE SULFATE | PHARMASCIENCE INC | Tablet | Oral | MORPHINE SULFATE 10 MG | Marketed | |
| 02549816 | PMS-MORPHINE SULFATE | PHARMASCIENCE INC | Tablet | Oral | MORPHINE SULFATE 25 MG | Approved | |
| 02549786 | PMS-MORPHINE SULFATE IR | PHARMASCIENCE INC | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 30 MG | Approved | |
| 02244790 | SANDOZ MORPHINE SR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Marketed | |
| 02244791 | SANDOZ MORPHINE SR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Marketed | |
| 02244792 | SANDOZ MORPHINE SR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Marketed | |
| 02478889 | SANDOZ MORPHINE SR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Marketed | |
| 02478897 | SANDOZ MORPHINE SR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Marketed | |
| 00594652 | STATEX | KNIGHT THERAPEUTICS INC. | Tablet | Oral | MORPHINE SULFATE 5 MG | Marketed | |
| 00594644 | STATEX | KNIGHT THERAPEUTICS INC. | Tablet | Oral | MORPHINE SULFATE 10 MG | Marketed | |
| 02302764 | TEVA-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Marketed | |
| 02302772 | TEVA-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Marketed | |
| 02302780 | TEVA-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Marketed | |
| 02302799 | TEVA-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Marketed | |
| 02302802 | TEVA-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Marketed | |
| 02254204 | ZOMORPH | ETHYPHARM INC | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 60 MG | Approved | |
| 02254182 | ZOMORPH | ETHYPHARM INC | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 20 MG | Approved | |
| 02254190 | ZOMORPH | ETHYPHARM INC | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 40 MG | Approved | |
| 02254220 | ZOMORPH | ETHYPHARM INC | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 200 MG | Approved | |
| 02254212 | ZOMORPH | ETHYPHARM INC | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 120 MG | Approved | |
| 02453878 | BAR-MORPHINE SR | BARD PHARMACEUTICALS (1990) INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Cancelled Pre Market | |
| 02453800 | BAR-MORPHINE SR | BARD PHARMACEUTICALS (1990) INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Cancelled Pre Market | |
| 02453827 | BAR-MORPHINE SR | BARD PHARMACEUTICALS (1990) INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Cancelled Pre Market | |
| 02453843 | BAR-MORPHINE SR | BARD PHARMACEUTICALS (1990) INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Cancelled Pre Market | |
| 02453851 | BAR-MORPHINE SR | BARD PHARMACEUTICALS (1990) INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Cancelled Pre Market | |
| 02009765 | M.O.S. SULPHATE 10MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | Oral | MORPHINE SULFATE 10 MG | Cancelled Post Market | |
| 02009749 | M.O.S. SULPHATE 25MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | Oral | MORPHINE SULFATE 25 MG | Cancelled Post Market | |
| 02009706 | M.O.S. SULPHATE 50MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | Oral | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 02009773 | M.O.S. SULPHATE 5MG TAB | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Tablet | Oral | MORPHINE SULFATE 5 MG | Cancelled Post Market | |
| 00869325 | MORPHINE EXTRA-FORTE | PFIZER CANADA ULC | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 00869317 | MORPHINE FORTE | PFIZER CANADA ULC | Solution | Intravenous; Intramuscular; Subcutaneous | MORPHINE SULFATE 25 MG | Cancelled Post Market | |
| 00676411 | MORPHINE HP 25 - 25MG/ML | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 25 MG | Cancelled Post Market | |
| 02350890 | MORPHINE SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Cancelled Post Market | |
| 02350920 | MORPHINE SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Cancelled Post Market | |
| 02350947 | MORPHINE SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Cancelled Post Market | |
| 02350912 | MORPHINE SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Cancelled Post Market | |
| 02350815 | MORPHINE SR | SANIS HEALTH INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Cancelled Post Market | |
| 01980696 | MORPHINE SULFATE INJ 1MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous | MORPHINE SULFATE 1 MG | Cancelled Post Market | |
| 01964437 | MORPHINE SULFATE INJ 2MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous | MORPHINE SULFATE 2 MG | Cancelled Post Market | |
| 01964429 | MORPHINE SULFATE INJ 5MG/ML USP | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intravenous | MORPHINE SULFATE 5 MG | Cancelled Post Market | |
| 02382970 | MORPHINE SULFATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 1 MG | Cancelled Pre Market | |
| 02383004 | MORPHINE SULFATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous; Intravenous; Intramuscular | MORPHINE SULFATE 15 MG | Cancelled Pre Market | |
| 02382989 | MORPHINE SULFATE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 2 MG | Cancelled Pre Market | |
| 00850314 | MORPHINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 2 MG | Cancelled Pre Market | |
| 00649619 | MORPHINE SULFATE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | MORPHINE SULFATE 5 MG | Cancelled Post Market | |
| 00636908 | MORPHINE SULFATE INJECTION USP | ICU MEDICAL CANADA INC | Solution | Intravenous | MORPHINE SULFATE 1 MG | Cancelled Post Market | |
| 00850330 | MORPHINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous; Subcutaneous; Intramuscular | MORPHINE SULFATE 15 MG | Cancelled Post Market | |
| 00850322 | MORPHINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | Intramuscular; Intravenous; Subcutaneous | MORPHINE SULFATE 10 MG | Cancelled Post Market | |
| 02482703 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Intravenous; Intramuscular; Subcutaneous | MORPHINE SULFATE 4 MG | Cancelled Pre Market | |
| 02482738 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous; Intravenous; Intramuscular | MORPHINE SULFATE 8 MG | Cancelled Pre Market | |
| 02482711 | MORPHINE SULFATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 5 MG | Cancelled Pre Market | |
| 00885509 | MORPHINE SULPHATE INJ 1MG/ML BP | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | Intravenous; Subcutaneous | MORPHINE SULFATE 1 MG | Cancelled Post Market | |
| 02137232 | MORPHINE SULPHATE INJECTION 1MG/ML | HOSPIRA HEALTHCARE ULC | Liquid | Intravenous; Subcutaneous | MORPHINE SULFATE 1 MG | Cancelled Post Market | |
| 02137240 | MORPHINE SULPHATE INJECTION 2MG/ML | HOSPIRA HEALTHCARE ULC | Liquid | Subcutaneous; Intravenous | MORPHINE SULFATE 2 MG | Cancelled Post Market | |
| 02137267 | MORPHINE SULPHATE INJECTION 50MG/ML | HOSPIRA HEALTHCARE ULC | Liquid | Intramuscular; Subcutaneous; Intravenous | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 02022672 | MORPHINE SULPHATE INJECTION B.P. 25MG/ML | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | Intravenous; Subcutaneous; Intramuscular | MORPHINE SULFATE 25 MG | Cancelled Post Market | |
| 02022680 | MORPHINE SULPHATE INJECTION B.P. 50MG/ML | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | Subcutaneous; Intramuscular; Intravenous | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 02003759 | MORPHINE SULPHATE INJECTION BP 2MG/ML | DAVID BULL LABORATORIES (CANADA) INC. | Liquid | Intravenous; Subcutaneous | MORPHINE SULFATE 2 MG | Cancelled Post Market | |
| 02010380 | MORPHINE SULPHATE INJECTION, USP | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous | MORPHINE SULFATE 25 MG | Cancelled Post Market | |
| 02009897 | MORPHINE SULPHATE INJECTION, USP LIQ50MG/ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 02010364 | MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | Intravenous; Refer (See Dosage Form) | MORPHINE SULFATE 1.1 MG | Cancelled Post Market | |
| 01949055 | MORPHINE-EPD | PFIZER CANADA ULC | Solution | Epidural | MORPHINE SULFATE 1 MG | Cancelled Post Market | |
| 01949047 | MORPHINE-EPD | PFIZER CANADA ULC | Solution | Epidural | MORPHINE SULFATE 0.5 MG | Cancelled Post Market | |
| 02146827 | MS CONTIN SUPPOSITORIES - 30MG | PURDUE PHARMA | Suppository (Sustained-Release) | Rectal | MORPHINE SULFATE 30 MG | Cancelled Post Market | |
| 02145952 | MS CONTIN SUPPOSITORIES - 100MG | PURDUE PHARMA | Suppository (Sustained-Release) | Rectal | MORPHINE SULFATE 100 MG | Cancelled Post Market | |
| 02145960 | MS CONTIN SUPPOSITORIES - 200MG | PURDUE PHARMA | Suppository (Sustained-Release) | Rectal | MORPHINE SULFATE 200 MG | Cancelled Post Market | |
| 02145944 | MS CONTIN SUPPOSITORIES - 60MG | PURDUE PHARMA | Suppository (Sustained-Release) | Rectal | MORPHINE SULFATE 60 MG | Cancelled Post Market | |
| 02229420 | MS CONTIN TABLETS | PURDUE PHARMA | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 5 MG | Cancelled Pre Market | |
| 02242831 | MS CONTIN XL CAPSULES | PURDUE PHARMA | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 150 MG | Cancelled Pre Market | |
| 02242830 | MS CONTIN XL CAPSULES | PURDUE PHARMA | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 120 MG | Cancelled Pre Market | |
| 02242832 | MS CONTIN XL CAPSULES | PURDUE PHARMA | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 200 MG | Cancelled Pre Market | |
| 02242827 | MS CONTIN XL CAPSULES | PURDUE PHARMA | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 30 MG | Cancelled Pre Market | |
| 02242828 | MS CONTIN XL CAPSULES | PURDUE PHARMA | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 60 MG | Cancelled Pre Market | |
| 02242829 | MS CONTIN XL CAPSULES | PURDUE PHARMA | Capsule (Sustained-Release) | Oral | MORPHINE SULFATE 90 MG | Cancelled Pre Market | |
| 02014173 | MS IR SUP 30MG | PURDUE PHARMA | Suppository | Rectal | MORPHINE SULFATE 30 MG | Cancelled Post Market | |
| 02014246 | MS IR SUP 10MG | PURDUE PHARMA | Suppository | Rectal | MORPHINE SULFATE 10 MG | Cancelled Post Market | |
| 02014262 | MS IR SUP 20MG | PURDUE PHARMA | Suppository | Rectal | MORPHINE SULFATE 20 MG | Cancelled Post Market | |
| 02346400 | NTP-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Cancelled Pre Market | |
| 02346397 | NTP-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Cancelled Pre Market | |
| 02346389 | NTP-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Cancelled Pre Market | |
| 02346370 | NTP-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Cancelled Pre Market | |
| 02346362 | NTP-MORPHINE SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Cancelled Pre Market | |
| 01988743 | ORAMORPH SR TABLETS 100MG | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Cancelled Post Market | |
| 01988727 | ORAMORPH SR TABLETS 30MG | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Cancelled Post Market | |
| 01988735 | ORAMORPH SR TABLETS 60MG | ROXANE LABS, DIVISION OF BOEHRINGER INGELHEIM | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Cancelled Post Market | |
| 02549778 | PMS-MORPHINE SULFATE IR | PHARMASCIENCE INC | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 20 MG | Cancelled Pre Market | |
| 02549743 | PMS-MORPHINE SULFATE IR | PHARMASCIENCE INC | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 5 MG | Cancelled Pre Market | |
| 02549751 | PMS-MORPHINE SULFATE IR | PHARMASCIENCE INC | Tablet (Immediate-Release) | Oral | MORPHINE SULFATE 10 MG | Cancelled Pre Market | |
| 02245287 | PMS-MORPHINE SULFATE SR 100 MG | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 100 MG | Cancelled Post Market | |
| 02245284 | PMS-MORPHINE SULFATE SR 15 MG | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 15 MG | Cancelled Post Market | |
| 02245288 | PMS-MORPHINE SULFATE SR 200 MG | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 200 MG | Cancelled Post Market | |
| 02245285 | PMS-MORPHINE SULFATE SR 30 MG | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 30 MG | Cancelled Post Market | |
| 02245286 | PMS-MORPHINE SULFATE SR 60 MG | PHARMASCIENCE INC | Tablet (Extended-Release) | Oral | MORPHINE SULFATE 60 MG | Cancelled Post Market | |
| 00705799 | STATEX DPS 50MG/ML | PALADIN PHARMA INC. | Drops | Oral | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 00621935 | STATEX DROPS 20MG/ML | PALADIN PHARMA INC. | Drops | Oral | MORPHINE SULFATE 20 MG | Cancelled Post Market | |
| 00596965 | STATEX SUPPOSITORIES 20MG | PALADIN PHARMA INC. | Suppository | Rectal | MORPHINE SULFATE 20 MG | Cancelled Post Market | |
| 00639389 | STATEX SUPPOSITORIES 30MG | PALADIN PHARMA INC. | Suppository | Rectal | MORPHINE SULFATE 30 MG | Cancelled Post Market | |
| 00632228 | STATEX SUPPOSITORIES 5MG | PALADIN PHARMA INC. | Suppository | Rectal | MORPHINE SULFATE 5 MG | Cancelled Post Market | |
| 00647217 | STATEX SYRUP 10MG/ML | PALADIN PHARMA INC. | Syrup | Oral | MORPHINE SULFATE 10 MG | Cancelled Post Market | |
| 00591467 | STATEX SYRUP 1MG/ML | PALADIN PHARMA INC. | Syrup | Oral | MORPHINE SULFATE 1 MG | Cancelled Post Market | |
| 00591475 | STATEX SYRUP 5MG/ML | PALADIN PHARMA INC. | Syrup | Oral | MORPHINE SULFATE 5 MG | Cancelled Post Market | |
| 00594636 | STATEX TABLET 25MG | PALADIN PHARMA INC. | Tablet | Oral | MORPHINE SULFATE 25 MG | Cancelled Post Market | |
| 00675962 | STATEX TABLETS 50MG | PALADIN PHARMA INC. | Tablet | Oral | MORPHINE SULFATE 50 MG | Cancelled Post Market | |
| 00632201 | STATEX-SUPPOSITORIES 10MG | PALADIN PHARMA INC. | Suppository | Rectal | MORPHINE SULFATE 10 MG | Cancelled Post Market |
Browse other molecules: